Dr Douglas Mann (Washington University School of Medicine, Missouri, US) meets host Dr Harriette Van Spall (McMaster University, Hamilton, CA) to discuss the findings from the Sacubitril/Valsartan in Advanced Heart Failure With Reduced Ejection Fraction Trial. 
The LIFE trial aimed to address a knowledge gap regarding the efficacy, safety, and tolerability of sacubitril/valsartan in advanced HFrEF patients.

Recorded remotely from Washington and Hamilton, 2021. 

Editor: Mirjam Boros